In August 2024, the FDA updated Tirzepatides shortage status to resolved. However, the FDA chose to review this decision as the result of a court case
Asia-Pacific is expected to be the fastest-growing region at a CAGR of 9.4% from 2026 to 2033, fueled by the rapidly increasing diabetic population, expanding healthcare infrastructure, rising healthcare expenditure, and improving access to advanced biologic therapies across China, India, Japan, and South Korea
More serious side effects are rare but can include pancreatitis, gallbladder problems, and potential thyroid concerns
The 12.5mg total per vial provides enough semaglutide for a multi-week supply depending on dose
What is the mechanism of action for GLP-1 medications like Ozempic in promoting weight loss